Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300074647Phase 3Not yet recruiting
Phase 3, randomised trial of dexamethasone in respiratory distress syndrome (RDS), transient tachypnea of the newborn (TTN), hypoglycaemia and 1 more (2 arms), sponsored by Nanjing Maternal and Child Health Hospital. Primary endpoints: neonatal respiratory distress syndrome, transient tachypnea of the newborn and 3 more. Planned start Sep 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300074647.